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Abstract
 
The extraordinary sensitivity of CD8
 

 
 T cells to recognize antigen impinges to a large extent
on the coreceptor CD8. While several studies have shown that the CD8
 

 
 chain endows CD8
with efficient coreceptor function, the molecular basis for this is enigmatic. Here we report that
cell-associated CD8
 

 
, but not CD8
 

 
 or soluble CD8
 

 
, substantially increases the avidity
of T cell receptor (TCR)-ligand binding. To elucidate how the cytoplasmic and transmem-
brane portions of CD8
 

 
 endow CD8 with efficient coreceptor function, we examined T1.4 T
cell hybridomas transfected with various CD8
 

 
 constructs. T1.4 hybridomas recognize a pho-
toreactive 
 
Plasmodium berghei
 
 circumsporozoite (PbCS) peptide derivative (PbCS (4-azidobe-
zoic acid [ABA])) in the context of H-2K
 
d
 
, and permit assessment of TCR-ligand binding by
TCR photoaffinity labeling. We find that the cytoplasmic portion of CD8
 

 
, mainly due to its
palmitoylation, mediates partitioning of CD8 in lipid rafts, where it efficiently associates with
p56
 
lck
 
. In addition, the cytoplasmic portion of CD8
 

 
 mediates constitutive association of CD8
with TCR/CD3. The resulting TCR-CD8 adducts exhibit high affinity for major histocom-
patibility complex (MHC)-peptide. Importantly, because CD8
 

 
 partitions in rafts, its interac-
tion with TCR/CD3 promotes raft association of TCR/CD3. Engagement of these TCR/
CD3-CD8/lck adducts by multimeric MHC-peptide induces activation of p56
 
lck
 
 in rafts,
which in turn phosphorylates CD3 and initiates T cell activation.
Key words: T lymphocytes • cytotoxicity • phosphorylation • protein-tyrosine kinase • 
plasmon resonance
 
Introduction
 
The coreceptor CD8 plays a key role in the activation of
mature CD8
 

 
 T cells. In the absence of CD8, or upon
blocking of CD8, activation of CD8
 

 
 T cells requires con-
siderably higher and longer TCR engagement (1–4). While
CD8 on peripheral T cell consists of a disulfide-linked 
 

 
and 
 

 
 chains, intestinal T cells, 
 

 
 T cells, and NK cells ex-
press homodimeric CD8
 

 
 (1, 2). Heterodimeric CD8
 

 
is a much more potent coreceptor than homodimeric
CD8
 

 
, but there is considerable controversy on what do-
mains of CD8
 

 
 and by what mechanism CD8
 

 
 endows
CD8 with efficient coreceptor function (1–8).
Using K
 
d
 
-restricted CD8
 

 
 T cells, which recognize a
photoreactive derivative of the Plasmodium berghei cir-
cumsporozoite (PbCS)
 
*
 
 peptide 252–260 (SYIPSAEKI)
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Branch, Chemin des Boveresses 155, 1066 Epalinges, Switzerland. Phone:
41-21-692-5988; Fax: 41-21-653-4474; E-mail: iluesche@eliot.unil.ch
 
*
 
Abbreviations used in this paper:
 
 CHO, Chinese hamster ovary; DIM, de-
tergent insoluble microdomains; LAT, linker for activation of T cells; lck,
p56
 
lck
 
; M, detergent soluble membrane fraction; PbCS, 
 
Plasmodium berghei
 
circumsporozoite; pY, phospho-tyrosine.
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(PbCS (4-azidobezoic acid [ABA])) and allow detection
of TCR-ligand interactions by TCR photoaffinity label-
ing, we have shown that on cells CD8
 

 
, but not
CD8
 

 
, substantially strengthens TCR-ligand binding
(4, 9–11). Similar findings have been obtained by stain-
ing of CD8
 

 
 T cells with fluorescent labeled MHC-
peptide multimers (12). Thus, the extraordinary sensitiv-
ity of CD8
 

 
 CTL to recognize target cells expressing
very few MHC-peptide complexes or low affinity
MHC-peptide variants is attributed to, at least in part,
the ability of CD8
 

 
 to enhance the avidity of TCR-
ligand binding.
Binding studies with soluble recombinant CD8 have
shown that CD8
 

 
 and CD8
 

 
 bind class I molecules
with similar affinities (13, 14). By contrast, cell-associated
CD8
 

 
 seems to bind MHC class I molecules more avidly
than CD8
 

 
 (3–5). According to one study, soluble
CD8
 

 
 enhances the binding of soluble TCR to MHC-
peptide (13). However, another study indicated that solu-
ble CD8
 

 
 has no effect on TCR-ligand binding, i.e., that
binding of soluble CD8 and TCR to MHC-peptide are
two independent events (15). Here we report that the ex-
tracellular portion of CD8
 

 
 in soluble form does not
strengthen the interaction of the T1 TCR with K
 
d
 
-PbCS
(ABA), indicating that the CD8-mediated increase in T1
TCR-ligand binding observed on cells (4, 10) is attributed
to the transmembrane and/or cytoplasmic portions of
CD8
 

 
.
The tail of CD8
 

 
 is 30 residues long and contains two
vicinal cysteines, which interact with the Src kinase p56
 
lck
 
(lck) by means of a zinc chelate complex (1, 2). The tail of
CD8
 

 
 contains 19 residues and seems to play an important
role for the positive selection and activation of CD8
 

 
 T
cells (5, 6–8, 16). We have shown previously that the
CD8
 

 
 tail is palmitoylated at a membrane-proximal cys-
teine and mediates CD8 partitioning in lipid rafts (6). Rafts,
also called detergent-insoluble membranes (DIMs), are or-
dered microdomains, enriched in sphingolipids and choles-
terol, which include molecules containing short saturated
fatty acids, such as GPI-linked proteins, or on the inner
membrane leaflet palmitoylated molecules, like CD8, lck,
p59fyn (fyn), and the linker for activation of T cells (LAT)
(6, 17–22). Other molecules are excluded from rafts,
namely phosphatases (e.g., CD45), which makes rafts privi-
leged sites for the induction of TCR signaling. Raft local-
ization of CD8 increases its association with lck, which is
important, because cross-linking-mediated lck activation in
rafts is a crucial initial event in T cell activation (6, 20). The
CD8
 

 
 tail has also been implicated in association of CD8
with LAT (5, 23).
In this study we prepared T1 T cell hybridomas express-
ing CD8
 

 
 and various CD8
 

 
 variants. We show that on
cells, the CD8
 

 
 cytoplasmic portion mediates association
of CD8 with TCR/CD3. The resulting TCR/CD3 ad-
ducts with CD8/lck are raft associated, exhibit increased
avidity for MHC-peptide, and upon cross-linking, induce
phosphorylation of lck and CD3 and mobilization of intra-
cellular calcium
 
Materials and Methods
 
Antibodies and Cell Culture.
 
The following antibodies were
obtained from American Type Culture Collection: anti-CD8
 

 
mAb 53.6.72, anti-CD8
 

 
 mAb H35–17, anti-CD8
 

 
 mAb
53.5.81, anti-TCRC
 

 
 mAb H57, anti-TCRC
 

 
 mAb H28, and
anti-CD3
 

 
 mAb HAM146. Anti-phospho-tyrosine (pY) mAb
4G10 and anti-lck mAb 3A5 were from Upstate Biologicals.
Anti-LAT, anti-lck, and anti-CD3
 

 
 polyclonal antibodies were
from Santa Cruz Biotechnology, Inc. Transfected Chinese ham-
ster ovary (CHO) cells were maintained in Glasgow minimum
essential medium (Life Technologies) supplemented with 25 
 
	
 
M
methionine sulfoximine and 5% dialyzed FCS, as described (14).
T cell hybridomas were cultured in DMEM (Life Technologies)
supplemented with 5% FCS (Life Technologies), penicillin/
streptomycin/neomycin (PSN; Life Technologies), and 50 
 
	
 
M
 

 
-mercaptoethanol.
 
Soluble CD8
 

 
, T1 TCR, and Biotinlyated K
 
d
 
-PbCS(ABA).
 
Soluble T1 TCR and CD8 were prepared essentially as described
(14). In brief, the cDNA encoding the extracellular portions of
the T1 TCR 
 

 
 and 
 

 
 chains were fused to the sequences encod-
ing the basic and acidic units of a leucine zipper, respectively.
The constructs were cloned into the pEE14GS vector using the
EcoRI site and stably transfected into CHO-K1 cells with yields
of 
 

 
8 mg/l. sT1 TCR was purified on H28-Sepharose, using
acid elution (pH 3.1). The extracellular portions of murine
CD8
 

 
 (residues 1–156) and CD8
 

 
 (residues 1–146) were fused
to basic and acidic leucine zipper, cloned into pEE14GS, and sta-
bly expressed in CHO-K1 cells, with yields of 
 

 
10 mg/l. sCD8
was purified on H35–17 Sepharose, using acid elution (pH 3.1).
Correct folding of the purified sCD8, was confirmed by ELISA
using five different anti-CD8 monoclonal antibodies (anti-CD8
 

 
mAb 53.6.72, 19/178 and anti-CD8
 

 
 mAb 53.5.8, KT112,
H35–17). Monomeric covalent K
 
d
 
-
 
125
 
”iodo-4-azidosalicylic acid
(IASA)”-YIPSAEK (ABA) I complexes (
 

 
2,000 Ci/mMol) were
prepared as described (6, 9, 20). Biotinylated K
 
d-
 
SYIP-
SAEK(ABA)I was obtained by refolding of K
 
d
 
 heavy chain and
human 
 

 
 2-microglobulin from 
 
Escherichia coli
 
 as described (20).
The monomers were biotinylated, purified, and oligomerized by
reaction with streptavidin (Molecular Probes) as described (6, 20).
 
CD8 Transfections of T1.4 Hybridomas.
 
T1.4 T cell hybrid-
omas and their CD8
 

 
 transfectants have been described previ-
ously (6, 10). The CD8
 

 
 cDNA, cloned in the pMI vector,
which contains human tailless CD2 (24), was mutated at position
 
178 (Tyr 
 
→ 
 
Stop) or 179 (Cys 
 
→ 
 
Ala) resulting in CD8
 


 
 and
CD8
 



 
, respectively, using the Quick-Change Mutagenesis Kit
(Stratagene). For the chimeric CD8
 

 
 construct 
 

 

 
 the CD8
 

 
 ex-
tracellular and transmembrane cDNA (residues 1–190) was fused
with the cytoplasmic CD8
 

 
 cDNA (residues 176–194). The
cDNA of the chimeric CD8
 

 
 construct 
 

 
 was obtained by fus-
ing the CD8 extracellular and transmembrane coding regions
(residues 1–175) with the cytoplasmic CD8 cDNA (residues
191–220). The different cDNA were cloned in the pMI vector
(24) and transfected into CD8, CD8 T1.4 hybridomas by
retroviral gene transfer using the Phoenix packaging cell line (24).
Phoenix cells were transfected using calcium phosphate precipita-
tion. After 4 d the cells were sorted and then cloned for high
CD2 expression using PE-labeled anti-CD2 mAb (BD PharMin-
gen) and a FACStar™ (Becton Dickinson).
Calcium Measurements and TCR Photoaffinity Labeling. P815
cells (106/ml) were pulsed or not with 1 	M of IASA-YIP-
SAEK(ABA)I or IASA-YISSAEK(ABA)I (P255S) and then UV
irradiated at 350 nm as described (6, 25). T cell hybridomas
(106/ml) were incubated with 5 	M Indo-1/AM (Sigma-Aldrich)
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at 37C for 45 min, washed in DMEM, and incubated with P815
cells at an E/T ratio of 1/3 for 2 min. Calcium-dependent Indo-1
fluorescence was measured on a FACStar™ as described (25).
TCR photoaffinity labeling of T1.4 hybridomas was performed
as described (9–11, 20). In brief, hybridomas (107/ml) were incu-
bated with Kd-125IASA-YIPSAEK(ABA)I for 2 h at 0–4C.
After UV-cross-linking at 312  20 nm the cells were washed
and lysed in RIPA buffer (50 mM HEPES [pH 7.4], 150 mM
NaCl, 1% Triton X-100, 0.5% sodium deoxycholate, 0.1% SDS,
2 mM EDTA, 1 mM PMSF, 10 	g/ml leupeptin, 10 	M pepsta-
tin A, 5 mM benzamidine, 2 	g/ml aprotinin) for 30 min on ice.
The detergent soluble fractions were immunoprecipitated with
H57-Sepharose and the samples analyzed by SDS-PAGE (10%,
reducing) and PhosphorImaging using a Fuji BAS1000 Phosphor-
Imager.
Isolation of DIM. T cell hybridomas (5  107) were lysed for
30 min on ice in MNE buffer (25 mM MES [pH 6.5], 150 mM
NaCl, 5 mM EDTA) containing 1% Triton X-100 (Sigma-
Aldrich). Alternatively, 0.5% Brij58 (Fluka) without EDTA was
used (21). The lysates were homogenized with a Dounce ho-
mogenizer (10 strokes) and fractionated on sucrose density gradi-
ents as described (6). The gradients were fractionated from the
top in 10 fractions. In some experiments the fractions 2–4 and 6–9
were pooled and referred to as DIM and detergent soluble
membrane (M) fractions, respectively. Surface biotinylation was
performed as described (6). For immunoprecipitation the frac-
tions were incubated with Sepharose-conjugated anti-CD8
mAb 53.6.72, anti-CD8 mAb H35–17, or anti-TCR mAb
H57 for 3 h at 4C. The immunoprecipitates were resolved on
SDS-PAGE (10%, reducing), Western blotted with streptavidin-
horseradish peroxidase (HRP; GIBCO BRL) or anti-CD8 an-
tiserum and revealed by enhanced chemoluminescence (ECL) as
described (6, 20).
Coimmunoprecipitations. To assess association of CD8 with
lck, hybridomas (107) were lysed in lysis buffer (1 ml; 50 mM
HEPES [pH 7.4], 150 mM NaCl, 1% Brij96 [Fluka], and protease
inhibitors) for 60 min on ice. After centrifugation for 20 min at
12,000 g and 4C, the supernatants were incubated for 3 h at 4C
with anti-CD8 mAb 53.6.72 or H35–17 conjugated to Sepharose
4B (6). After two washes with lysis buffer, the samples were ana-
lyzed by SDS-PAGE (10%, reducing) and Western blotting using
anti-lck mAb 3A5. To detect association of CD8 with TCR/
CD3, cells (2  107) were lysed likewise in 1 ml lysis buffer con-
taining 0.3% NP-40 (Sigma-Aldrich) instead of Brij96. After one
wash with lysis buffer, the immunoprecipitates were analyzed by
SDS-PAGE (10%, reducing) and Western blotting using anti-
CD8 antiserum.
Analysis of lck and CD3 Tyrosine Phosphorylation. T1.4 hy-
bridomas (5  107) were incubated in DMEM (5 ml), supple-
mented with 1% BSA and 10 mM HEPES (pH 7.4) with 50 nM
of Kd SYIPSAEK(ABA)I tetramer for 20 min at 26C followed
by 2 min at 37C. The cells were lysed in 1 ml of MNE buffer
containing 1% Triton X-100, protease inhibitors (see above), 1
mM Na3VO4, and 10 mM NaF for 30 min on ice. The DIM
fractions were lysed in 1 ml RIPA buffer supplemented with
protease and phosphatase inhibitors. The soluble fractions were
incubated for 3 h at 4C with anti-CD3 HAM146-Sepharose or
Protein A Sepharose, preincubated with anti-lck antiserum. Af-
ter two washes with lysis buffer, the immunoprecipitates were
analyzed by SDS-PAGE and Western blotting with anti-pY
mAb 4G10.
BIAcore Measurements. Surface plasmon resonance (SPR)
studies were performed on a BIAcore 2000 (BIAcore AB) as de-
scribed previously (15, 26). In brief, streptavidin (Sigma-
Aldrich) was covalently coupled to Research Grade CM5 sensor
chips using the Amine Coupling Kit (BIAcore). Coupling levels
ranged from 6,000 to 8,000 response units (RU). Biotinylated
Kd-SYIPSAEK(ABA) or, as control, soluble human CD4
(sCD4), were immobilized via streptavidin. To eliminate aggre-
gates, sCD8 and sT1 TCR were purified by gel-filtration on
a Superdex S-200 column (Amersham Pharmacia Biotech) and
used within 24 h. Experiments were performed at 25C using
HBS buffer (10 mM HEPES [pH 7.4], 150 mM NaCl, 3.4 mM
EDTA, and 0.005% Surfactant P20; BIAcore) and a flow-rate of
10 	l/ml.
Results
Soluble CD8 and T1 TCR Bind Independently to Kd-
PbCS(ABA). To assess whether the extracellular portion
of CD8 affects TCR-ligand binding, we prepared solu-
ble CD8 and T1 TCR. Purified soluble sT1 TCR was
tested for ligand binding by TCR photoaffinity labeling
with soluble Kd-125“IASA”-YIPSAEK(ABA)I (9–11). After
UV irradiation it exhibited on reducing SDS-PAGE gels
one labeled specie of 80–90 kD corresponding to the com-
plex of sKd-PbCS (ABA) and one chain of the T1 TCR.
This material was immunoprecipitated with anti-TCRC
mAb H57 or anti-TCRC mAb H28, confirming the het-
erodimeric nature of the sT1 TCR. To ascertain the bio-
logical activity of the soluble CD8, it was tested as in-
hibitor in a cytolytic assay using PbCS(ABA) pulsed P815
cells as targets. Increasing concentrations of sCD8 inhib-
ited the lysis of P815 cells by cloned PbCS(ABA)-specific
S14 CTL, with a half maximal inhibition at 0.66 mg/ml
(10 	M), and maximal inhibition of 80% at 2 mg/ml (data
not shown), indicating that sCD8 competes with cell-
associated CD8.
SPR studies were performed to assess the interactions of
sT1 TCR and sCD8 with immobilized Kd-PbCS(ABA).
As shown in Fig. 1 A, sT1  bound to Kd-PbCS(ABA) in
a dose-dependent manner with an equilibrium constant KD
of 4  0.4 	M. No binding was detectable when HLA-
A2-flu matrix peptide complexes or CD4 were used in-
stead of Kd-PbCS(ABA) or sT1 TCR (data not shown).
sCD8 bound also in a dose-dependent manner to im-
mobilized Kd-PbCS(ABA) (Fig. 1 B), but with low affinity
(KD 99  10 	M), which is in agreement with published
values (13, 14). To determine whether CD8 affects
TCR-ligand binding, sT1 TCR was tested for binding to
immobilized Kd-PbCS(ABA) in the presence or absence of
80 	M of sCD8. As shown in Fig. 1 C, sCD8 did not
increase the binding of sT1 TCR to Kd-PbCS(ABA). Con-
sistent with this we found that sCD8 has no effect on
TCR photoaffinity labeling on CD8 T1.4 cell hybrid-
omas (data not shown). These findings demonstrate that
sCD8 does not affect the interaction of T1 TCR with
Kd-PbCS(ABA). This is in accordance with a study show-
ing that CD8 has no effect on TCR-ligand binding
(15), but not with another study claiming that soluble
CD8 does (13).
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The CD8 Transmembrane and Cytoplasmic Portions Are
Required for Efficient Intracellular Calcium Mobilization in
CD8-transfected T1.4 Hybridomas. To evaluate the role of
CD8 transmembrane and cytoplasmic portions for CD8
coreceptor function, we transfected CD8 T1.4 hybrid-
omas (6, 10) with CD8 or the CD8 variants shown in
Fig. 2. While the T1 CTL clone expresses only CD8,
the hybridomas express substantially more CD8 than
CD8, i.e., express homodimeric CD8 and hetero-
dimeric CD8. The different hybridomas were tested
for intracellular calcium mobilization upon incubation
with P815 cells sensitized with IASA-YIPSAEK(ABA)I.
CD8 cells exhibited higher calcium mobilization than
the other cells (Fig. 3 A). More striking differences among
the different cells emerged, when the peptide variant
IASA-YISSAEK(ABA)I (P255S) was used, which is a weak
agonist for T1 CTL (25). In this case, the CD8 cells
displayed nearly the same calcium mobilization as observed
for the wild-type peptide, whereas no change was observed
in CD8 or CD8 cells. Hybridomas expressing
CD8
 or CD8 responded less efficiently than those
expressing CD8

 or CD8.
We also measured intracellular calcium mobilization of
the indicated hybridomas after incubation with Kd-SYIP-
SAEK(ABA)I tetramer. As shown in Fig. 3 B, only cells
expressing CD8, but not those expressing no CD8,
CD8, or CD8
 exhibited significant increase in in-
tracellular calcium upon incubation with tetramer. As as-
sessed by staining with Cy5 labeled tetramer, binding was
maximal on all cells under the indicated conditions (data
not shown).
The CD8 Tail Is Essential for CD8 Partitioning in Rafts
and Efficient Association with lck. As CD8 association with
lck seems to take place preferentially in rafts (6), we exam-
ined the partitioning of the different CD8 molecules in
rafts. To this end the different cells were fractionated in
Figure 1. Soluble CD8 binds to Kd-PbCS(ABA) without affecting
its interaction with T1 TCR. For affinity measurements sT1 TCR (A)
and sCD8 (B) were injected for 30 s at the indicated concentrations
over surfaces expressing Kd-SYIPSAEK(ABA)I (4,500 RU) or sCD4
(4,200 RU). Binding was calculated as the difference in the observed
equilibrium response between the Kd-SYIPSAEK(ABA)I and the control
sCD4 flow cells. The solid lines represent nonlinear fits of the Langmuir
binding isotherm to the data, which yielded the indicated KD values. The
maximal binding was 2,600 RU for sT1 TCR and 1,200 RU for
sCD8. The insets show Scatchard transformations of the same data. (C)
The indicated concentrations of sT1 TCR were injected for 30 s over
Kd-SYIPSAEK(ABA)I (2,000 RU) or CD4 (2,300 RU) coated sensor
chips in the absence () or presence () of added sCD8 (80 	M).
The calculated difference in the responses observed with sT1 alone versus
sT1 plus sCD8 are also shown (). The binding level observed with
sCD8 alone at 80 	M is shown as dashed line, indicating that the ef-
fect of adding sCD8 on sT1 binding was never more than additive.
Figure 2. TCR and CD8 expression of cells under study.
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Triton X-100 soluble (M) and insoluble (DIM) fractions
and their CD8 content assessed. As shown in Fig. 4 A,
CD8 and C8, efficiently partition in DIM, whereas
CD8
 and CD8

 did not. Thus, mutation of Cys179
of CD8 impaired CD8 association with rafts as dramati-
cally as deletion of the CD8 tail. Interestingly CD8
was significantly more raft-associated as compared with
CD8
 and CD8

, indicating that the transmembrane
portion of CD8 is also involved in the recruitment of
CD8 to rafts. Essentially the same results were obtained,
whether or not EDTA was present in the lysis buffer, i.e.,
whether or not CD8 could associate with lck (data not
shown). These results show that raft-association of CD8 is
essentially mediated by the CD8 tail and this mainly due
to palmitoylation of its Cys 179.
We next examined the association of CD8 with lck by
coimmunoprecipitation. For simplicity we used here total
Brij96 lysates, rather than M and DIM fractions, as this de-
tergent has been used previously to assess CD8 association
with lck (6–8). As the CD8 transfectants under study ex-
press CD8 and CD8 (Fig. 2), we performed immu-
noprecipitation with anti-CD8 mAb, which precipitates
CD8 and CD8 (Fig. 4 B), as well as with anti-CD8
mAb, which precipitates only CD8 (Fig. 4 C). We find
that CD8 and CD8 associate more efficiently with
lck, compared with CD8, CD8
, CD8

, and
CD8. The superior lck association with CD8 was
especially visible in anti-CD8 immunoprecipitates. This
is so, because these cells express substantially higher
amounts of CD8 than CD8. Thus, even though the
association of CD8 with lck is weak, it is well visible
due to its high expression. The amounts of CD8 in anti-
CD8 or CD8 immunoprecipitates were comparable for
the different hybridomas (Fig. 4, D and E). These results
demonstrate that efficient association of CD8 with lck
takes place in rafts.
Figure 3. Efficient calcium mobilization of T1.4 hybridomas requires that they express CD8 transmembrane and cytoplasmic portions. (A) Indo-1–
labeled hybridomas with the indicated CD8 expression were incubated with P815 cells either untreated (control) or previously sensitized with 1 	M of
IASA-YIPSAEK(ABA)I (PbCS(ABA) wt) or IASA-YISSAEK(ABA)I (PbCS(ABA) P255S) at an E/T ratio of 1/3 for 3 min at 37C and calcium-depen-
dent Indo-1 fluorescence was measured by FACS®. (B) Alternatively the indicated Indo-1–labeled cells were incubated or not (control) with Kd-
PbCS(ABA) tetramer (50 nM) and calcium flux was measured likewise after 2 min of incubation at 37C. One out of three experiments is shown.
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As it has been reported that CD8 associates with LAT, in
a manner similar as it associates with lck (5, 23), we West-
ern blotted the same CD8 immunoprecipitates with anti-
LAT antibody. Even though LAT was well detectable in
total lysates, no LAT was found in the CD8 immunopre-
cipitates (data not shown).
CD8 Tail Is Required for CD8-mediated Increase in TCR-
ligand Binding. To assess the ability of the various CD8
constructs to strengthen TCR-ligand binding, we TCR
photoaffinity labeled the different cells with soluble, mono-
meric Kd-125”IASA”-YIPSAEK(ABA)I. As shown in Fig.
5, T1 TCR photoaffinity labeling was highest on CD8
cells. In the presence of anti-CD8 mAb H35–17, which
blocks binding of CD8 to TCR-associated Kd-PbCS(ABA)
(10), TCR photoaffinity labeling was reduced by 12-fold,
to the same low levels observed on CD8 cells. CD8
was quite unable to increase TCR-ligand binding, which is
consistent with previous findings in a related system (4).
Importantly, deletion of the cytoplasmic domain of
CD8 (CD8
) or substitution with the one of CD8
(CD8) caused a significant (67%) reduction in TCR
photoaffinity labeling, demonstrating that the CD8 tail is
required for efficient CD8-mediated increase of TCR-
ligand binding. By contrast, mutation of CD8 Cys 179
(CD8

) caused only a modest decrease in TCR photo-
affinity labeling. As this variant poorly associates with lck
(6; Fig. 4), it appears that CD8/lck supports TCR-ligand
binding somewhat better than CD8 alone. It is note-
worthy that CD8
 and CD8 exhibit partially in-
creased TCR photoaffinity labeling as compared with
CD8, indicating that the extracellular and/or transmem-
brane regions of CD8 also play a role in enhancing TCR
interactions with MHC-peptide.
The CD8 Tail Mediates Constitutive Association of CD8
with TCR/CD3. Our results so far indicate that CD8
increases the avidity of TCR-ligand binding on cells, but
not in solution and that the tail of CD8 is needed for this
effect (Figs. 1 and 5). We next examined whether this is so,
because on cells CD8 associates with the TCR. To this
end, we lysed hybridomas expressing no CD8, CD8,
Figure 4. Palmitoylation of CD8 is essential for CD8
localization in rafts and efficient lck association. (A) T1.4
hybridomas with the indicated CD8 expression were sur-
face-biotinylated, lysed in cold TX-100 (1%), and fraction-
ated in M and DIM fractions. These were immunoprecipi-
tated with anti-CD8 mAb 53.6.72. The samples were
analyzed by SDS-PAGE and Western blotting with
streptavidin. (B–E) T1.4 hybridomas with the indicated
CD8 expression were lysed in Brij96 (1%) and the lysates
immunoprecipitated with mAb 53.6.72 (B and D) or anti-
CD8 mAB H35–17 (C and E). The immunoprecipitates
were analyzed by SDS-PAGE and Western blotting with
anti-lck mAb 3A5 (B and C) or anti-CD8 antiserum (D
and E). Note that anti-CD8 mAb H35 is unable to pre-
cipitate CD8 and CD8. One out of two experi-
ments is shown.
Figure 5. The cytoplasmic tail of CD8 is required for efficient CD8-
mediated increase in TCR photoaffinity labeling. T1.4 hybridoma cells
(5  106/ml) with the indicated CD8 expression were incubated for 2 h
at 0–4C with soluble monomeric Kd-125”IASA”-YIPSAEK(ABA)I (2–6 
106 cpm/ml) in the absence or presence of anti-CD8 mAb H35–17 (10
	g/ml). After UV irradiation cells were lysed in RIPA buffer, TCR im-
munoprecipitated, and analyzed by SDS-PAGE and PhosphorImaging.
Mean values and SD were calculated from six experiments.
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CD8, CD8
, or CD8

 in 0.3% NP-40 and im-
munoprecipitated TCR. As shown in Fig. 6 A, the amount
of CD8 coimmunoprecipitated with TCR was substan-
tially higher on CD8 or CD8

 cells, than on
CD8 or CD8
 cells. These differences were not
accounted for by variations of TCR or CD8 expression, as
all cells expressed comparable levels of CD3, CD8, and
CD8 (Fig. 6, B and C).
To find out whether Kd-PbCS(ABA) complexes
strengthen association of CD8 with TCR, CD8
cells were photo–cross-linked with soluble Kd-SYIP-
SAEK(ABA)I complexes and analyzed as described in the
previous paragraph. No significant increase in CD8 associa-
tion with TCR/CD3 was observed (Fig. 6 D), indicating
that the interaction of CD8 with TCR/CD3 is consti-
tutive and not induced by MHC-peptide. Moreover, the
coimmunoprecipitation was not impaired by the SH2 pep-
tide pYEEI (data not shown), which has been shown to
disrupt activation-induced coupling of CD8 to TCR/CD3
via lck and ZAP-70 (27). Constitutive association of CD8
(and CD4) with TCR/CD3 has been reported previously
and low concentrations of NP-40 or Triton X-100 have
been recommended to preserve these interactions (28–30).
Essentially the same findings where obtained when Brij78
was used, which unlike NP-40 and Triton X-100 solubi-
lizes lipid rafts, indicating that raft integrity was not re-
quired for this interaction (data not shown).
CD8 Mediates Raft-association of TCR/CD3. As the
previous experiments indicated that CD8 mediates associ-
ation of CD8 with lck in rafts (Fig. 4), as well as with
TCR/CD3 (Fig. 6), we examined whether therefore
CD8 induces raft-association of TCR/CD3. To this end
we TCR photoaffinity labeled T1.4 T cell hybridomas that
expressed CD8, CD8
, CD8
 or no CD8 with
soluble Kd-125”IASA”-YIPSAEK(ABA)I and fractionated
their Brij58 lysates on sucrose density gradients. Brij58 was
used rather than Triton X-100, because it better preserves
weak molecular interaction of membrane proteins (21).
This difference becomes especially apparent after long peri-
ods of incubation, such as fractionation on sucrose density
gradients. As shown in Fig. 7, the DIM-containing light
fractions exhibited substantial amounts of photoaffinity la-
beled TCR on CD8 cells, but not on cells expressing
CD8
, CD8

, or no CD8. Cells expressing CD8
Figure 6. The CD8 tail mediates CD8 association with TCR/CD3.
(A–C) T1.4 hybridomas with the indicated CD8 expression were lysed in
0.3% NP-40, and lysates immunoprecipitated with anti-TCR mAb H57
(A and B), anti-CD8 mAb 53.6.72 (C, left), or with anti-CD8 mAb
H35–17 (C, right). The samples were analyzed by SDS-PAGE and West-
ern blotting with anti-CD8 antiserum (A and C) or anti-CD3 antise-
rum (B). (D) T1.4 T cell hybridomas expressing CD8 or CD8 were
incubated with monomeric Kd-SYIPSAEK(ABA)I complexes (1.16
	M) for 2 h at 0–4C. After UV irradiation the cells were lysed in 0.3%
NP-40. Lysates were immunoprecipitated with anti-TCR mAb H57 or
anti-CD8 mAb 53.6.72, as indicated and the immunoprecipitates ana-
lyzed by SDS-PAGE and Western blotting with anti-CD8 antiserum.
Figure 7. CD8 mediates raft association of TCR/CD3. T1.4 hy-
bridomas (5  107) expressing no CD8 (A), CD8 (B), CD8
 (C), or
CD8

 (D) were photoaffinity labeled at 26C with Kd-125”IASA”-
YIPSAEK(ABA)I (0.5–1.5  108 cpm/7 ml). After UV irradiation the
washed cells were lysed in 0.5% Brij58 and the lysates fractionated on su-
crose density gradients. Fractions were collected from the top and immu-
noprecipitated with anti-TCRC mAb H57. The immunoprecipitates
were analyzed by SDS-PAGE and PhosphorImaging.
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also lacked significant amounts of photoaffinity labeled
TCR in the light fractions (data not shown). The gradient
fractions displayed the expected distributions of thy-1,
which is a marker of rafts and CD45, which is excluded
from rafts (data not shown, and references 17–21). These
findings indicate that the association of TCR/CD3 with
CD8 promotes association of TCR/CD3 with rafts, and
that tail of CD8 is required for this.
CD8 Hybridomas Exhibit Strong lck and CD3 Phos-
phorylation in Response to Kd-PbCS(ABA) Tetramer. To
correlate the intracellular calcium mobilization with activa-
tion of signaling molecules, we assessed lck phosphoryla-
tion in the different CD8 transfectants. The cells were
stimulated with Kd-SYIPSAEK(ABA)I tetramer and lck ty-
rosine phosphorylation assessed in DIM fractions. CD8
cells displayed strong lck tyrosine phosphorylation upon in-
cubation with Kd-SYIPSAEK(ABA)I tetramer, while cells
expressing no CD8 or CD8, CD8
, or CD8


cells exhibited only background lck phosphorylation (Fig.
8, A and B). In accordance with this, CD3 tyrosine phos-
phorylation was highest in CD8 cells activated by Kd-
SYIPSAEK(ABA)I tetramer, in particular of the pp23 hy-
perphosphorylated form (Fig. 8 C). In the M fractions the
same pattern of tyrosine phosphorylated lck was discernible
in the presence, but not absence of phosphatase inhibitors
(data not shown).
Discussion
The extraordinary sensitivity of antigen recognition by
CD8 T cells, namely CTL, impinges to a high degree on
the coreceptor CD8. As CD8 is a much less efficient
coreceptor, as compared with CD8 (1, 2; Fig. 3), we in-
vestigated the molecular basis by which CD8 endows
CD8 with efficient coreceptor function. Binding studies
with soluble recombinant proteins showed that TCR bind
cognate MHC-peptide in general with low affinity (KD of
104 to 106 M) (31). Our experiments with soluble
CD8 demonstrate that the extracellular portion of
CD8 has no effect on TCR-ligand binding (Fig. 1, and
unpublished results). By contrast, using TCR photoaffinity
labeling, we find that on cells CD8, but not CD8,
increases the avidity of TCR-ligand binding by a factor of
10 or more (4, 9–11; Fig. 5). Taken together, this implies
that the CD8-mediated increase in TCR-ligand binding
observed on cells is attributed to the transmembrane and/or
cytoplasmic portions of CD8.
The observation that deletion of the tail of CD8
greatly reduces CD8-mediated increase in TCR-ligand
binding on cells (Fig. 5), as well as of association of CD8
with TCR/CD3 (Fig. 6), indicates that these two effects
are related. As CD8 and CD8’ still caused a modest
increase in TCR-ligand binding (Fig. 5), it appears that
the transmembrane portion of CD8 also contributes
to the association of CD8 with TCR/CD3. Consistent
with this is the observation that hybridomas expressing
CD8, which lacks the transmembrane, but not the cy-
toplasmic portion of CD8, recognizes antigen poorly,
even though they exhibit good association of CD8 with
lck (Figs. 3 A and 4).
It is not clear how the CD8 tail interacts with TCR/
CD3 and to what extent the CD8 transmembrane portion
is involved in this interaction. The CD8 and to a lesser
degree the CD8 tail contain abundant positive charges
(Fig. 9). By contrast the NH2 terminus of lck, which is
membrane associated because it is palmitoylated (35, 36)
and the membrane proximal cytoplasmic sequence of LAT
are negatively charged and hence likely to undergo elec-
Figure 8. T1.4 cells expressing CD8 exhibit strong
lck and CD3 tyrosine phosphorylation in DIM upon in-
cubation with Kd-PbCS(ABA) tetramer. (A–C) T1.4 hy-
bridomas with the indicated CD8 expression were incu-
bated with or without Kd-SYIPSAEK(ABA)I tetramer
(50 nM) for 3 min at 37C. The cells were lysed in 1%
TX-100 and fractionated in M and DIM. DIM fractions
were immunoprecipitated with anti-lck (A and B) antise-
rum or anti-CD3 mAb HAM 146 (C). The samples were
analyzed by SDS-PAGE and Western blotting with anti-
pY mAb 4G10 (A and C), or anti-lck mAb 3A5 (B). A
representative experiment out of three is shown.
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trostatic interactions with the CD8 tails (Fig. 9). Remark-
ably, this LAT sequence becomes highly negatively
charged upon activation-dependent phosphorylation of its
tyrosines and serine/threonines (37–39) and thus is ex-
pected to undergo strong electrostatic interactions with
CD8. Differences in LAT phosphorylation may explain
why we were unable to detect association of LAT with
CD8, as has been observed in other systems (5, 23). The
membrane proximal cytoplasmic sequences of CD3,
CD3, and CD3, similarly become acidic upon phos-
phorylation of their serines/threonines.
Association of CD8 (and CD4) with TCR/CD3 has
been previously observed in different systems (28–30). Of
particular interest is a study showing that anti-CD8 immu-
noprecipitates contain a high proportion of CD3, suggest-
ing that CD8 associates with TCR via CD3 (28). This
may explain why mice lacking CD3 (32), or expressing a
variant TCR which fails to associate with CD3 (33), ex-
hibit severely impaired activation and positive selection of
CD8 T cells. It is important to note that the association of
CD8 with TCR/CD3 described here (Fig. 6) and in previ-
ous studies (28–30) is constitutive, i.e., is not, or little, in-
duced by MHC-peptide.
Moreover, the tail of CD8 mediates raft localization of
CD8 (6, 20; Fig. 4). The finding that point mutation of
CD8 Cys 179 (CD8

) abolishes this (Fig. 4 A), dem-
onstrates that this is attributed essentially to palmitoylation
of the CD8 tail. As lck is myristoylated and dipalmitoy-
lated, it also efficiently partitions in rafts (17–19, 35, 36).
Thus, the observation that efficient association of CD8
with lck takes place in rafts (6; Fig. 4), is most likely ex-
plained by increased concentrations of both molecules in
microdomains, which constitute only a small fraction of the
cell membrane (17). By contrast, association of CD8 with
TCR/CD3 and hence TCR-ligand binding were greatly
impaired upon deletion of the CD8 tail, but hardly by
mutation of CD8 Cys 179 (Figs. 5 and 6). This demon-
strates that the tail of CD8 exerts two different functions:
(a) it mediates raft localization of CD8 and hence efficient
association of CD8 with lck, and (b) it mediates association
of CD8 with TCR/CD3. Because CD8 exerts both
functions at the same time, it promotes raft-association of
TCR/CD3 (Fig. 7).
While TCR/CD3 per se do not partition significantly in
rafts (19–22), this study indicates that they become raft-
associated by interacting with raft-resident CD8-lck com-
plexes. Small fractions of TCR/CD3 have been shown to
be raft-associated in resting cells in a fractionation study
(21) and by confocal microscopy (40). Although CD3
components seem to bind weakly to raft-associated Src ki-
nases in resting cells, which may be important for corecep-
tor independent T cell activation (41), we show here that
CD8 substantially strengthens raft-association of TCR/
CD3 (Fig. 7). As association of TCR/CD3 with CD8/lck
also enhances the avidity of TCR-ligand binding (20; Fig.
5), it appears that raft-associated TCR have an increased
avidity for MHC-peptide, i.e., are those that are engaged
first by MHC-peptide, particularly when these are scant or
of low affinity. Thus, for the induction of TCR signaling
this constitutive TCR/CD3 association with CD8/lck is
important, as it provides a significant increase in TCR-
ligand binding and at the same time raft association of en-
gaged TCR/CD3 (Figs. 5–8).
Because phosphatases are excluded from rafts, they are
privileged sites for the induction of TCR signaling (19–
22). Indeed we find that tetrameric Kd-PbCS(ABA) com-
plexes efficiently induce tyrosine phosphorylation of lck
and CD3 in rafts on CD8 hybridoma, but much less
so on hybridomas expressing no CD8, CD8, CD8
,
or CD8

 (Fig. 8). As lck is activated by cross-linking,
even when Y505 is phosphorylated (6–8, 20, 42), our data
propose that TCR signaling is induced by engagement of
raft-associated TCR/CD3 adducts with CD8/lck by mul-
timeric MHC-peptide complexes. While it is clear that
once TCR signaling is induced, SH2-mediated interactions
provide additional coupling of the TCR/CD3 with CD8,
LAT, ZAP-70, and other molecules (1, 27, 34), the present
study shows that CD8 significantly facilitates TCR signal
Figure 9. Membrane proxi-
mal cytoplasmic sequences of
CD3, CD8, lck and LAT. The
indicated sequences were taken
from Swiss-Prot (http://www.
expasy.ch/cgi-bin/sprotsearch-de).
Cysteines labeled with an asterisk
are known to be palmitoylated
and hence are membrane inte-
grated. The numbers of the dis-
played residues are indicated in
parenthesis. Basic residues are
shown in oval, acidic ones in
boxes, tyrosines in diamonds,
and serines and threonines in
shaded gray.
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induction, by increasing the avidity of TCR-ligand binding
and by docking TCR/CD3 to rafts.
We thank Drs. M. Bevan for his generous gift of the pMI vector,
H.-C. Chang for the plasmids encoding the leucine zippers and
helpful advice, and J.-C. Cerottini for valuable discussions. We are
grateful to Pierre Zaeck for help with cell sorting.
Submitted: 2 April 2001
Revised: 7 August 2001
Accepted: 21 August 2001
References
1. Janeway, C.A., Jr. 1992. The T cell receptor as a multicom-
ponent signaling machine: CD4/CD8 coreceptors and CD45
in T cell activation. Annu. Rev. Immunol. 10:645–674.
2. Zamoyska, R. 1994. The CD8 coreceptor revisited: one
chain good, two chains better. Immunity. 1:243–246.
3. Wheeler, C.J., J.-Y. Chen, T.A. Potter, and J.R. Potter.
1998. Mechanism of CD8-mediated T cell response en-
hancement: interaction with MHC class I-2-microglobulin
and functional coupling to TCR/CD3. J. Immunol. 160:
4199–4207.
4. Renard, V., P. Romero, E. Vivier, B. Malissen, and I.F. Lue-
scher. 1996. CD8 increases CD8 coreceptor function and
participation in TCR-ligand binding. J. Exp. Med. 184:
2439–2444.
5. Bosselut, R., S. Kubo, T. Guinter, J.L. Kopacz, J.D. Altman,
L. Feigenbaum, and A. Singer. 2000. Role of CD8beta do-
mains in CD8 coreceptor function: importance for MHC I
binding, signaling, and positive selection of CD8 T cells in
the thymus. Immunity. 12:409–418.
6. Arcaro, A., C. Gregoire, N. Boucheron, S. Stotz, E. Palmer,
B. Malissen, and I.F. Luescher. 2000. Essential role of CD8
palmitoylation in CD8 coreceptor function. J. Immunol. 165:
2068–2076.
7. Irie, H.Y., K.S. Ravichandran, and S.J. Burakoff. 1995.
CD8 chain influences CD8 chain-associated Lck kinase
activity. J. Exp. Med. 181:1267–1273.
8. Irie, H.Y., M.S. Mong, A. Itano, M.E. Crooks, D.R. Litt-
man, S.J. Burakoff, and E. Robey. 1998. The cytoplasmic
domain of CD8 regulates Lck kinase activation and CD8 T
cell development. J. Immunol. 161:183–191.
9. Luescher, I.F., J.C. Cerottini and P. Romero. 1994. Photoaf-
finity labeling of the T cell receptor on cloned cytotoxic T
lymohocytes by covalent photoreactive ligand. J. Biol. Chem.
269:5547-5582.
10. Luescher, I.F., E. Vivier, A. Layer, J. Mahiou, F. Godeau, B.
Malissen, and P. Romero. 1995. CD8 modulation of T-cell
antigen receptor-ligand interactions on living cytotoxic T
lymphocytes. Nature. 373:353–356.
11. Luescher, I.F., F. Anjuere, M.C. Peitsch, C.V. Jongeneel,
J.C. Cerottini, and P. Romero. 1995. Structural analysis of
TCR-ligand interactions studied on H-2Kd-restricted cloned
CTL specific for a photoreactive peptide derivative. Immu-
nity. 3:51–63.
12. Daniels, M.A., and S.C. Jameson. 2000. Critical role for CD8
in T cell receptor binding and activation by peptide/major
histocompatibility complex multimers. J. Exp. Med. 191:335.
13. Garcia, K.C., C.A. Scott, A. Brunmark, F.R. Carbone, P.A.
Petersen, I.A. Wilson, and L. Teyton. 1996. CD8 enhances
formation of stable T-cell receptor/MHC class I molecule
complexes. Nature. 384:577–581.
14. Kern, P., R.E. Hussey, R. Spoerl, E.L. Reinherz, and H.-C.
Chang. 1999. Expression, purification, and functional analysis
of murine ectodomain fragments of CD8 and CD8
dimers. J. Biol. Chem. 274:27237.
15. Wyer, J.R., B.E. Willcox, G.F. Goa, U.C. Gerth, S.J. Davis,
J.I. Bell, A. van der Merwe, and B.K Jakobsen. 1999. T cell
receptor and coreceptor CD8 bind peptide-MHC inde-
pendently and with distinct kinetics. Immunity. 10:219–225.
16. Itano, A., D. Cado, F.K.M. Chan, and E. Robey. 1994. A
role for the cytoplasmic tail of the  chain of CD8 in thymic
selection. Immunity. 1:287–290.
17. Simons, K., and D. Toomre. 2000. Lipid rafts and signal
transduction. Nat. Mol. Biol. 1:31–38.
18. Melkonian, K.A., A.G. Ostermeyer, J.Z. Chen, M.G. Roth,
and D.A. Brown. 1999. Role of lipid modifications in target-
ing proteins to detergent-resistant membrane rafts. Many raft
proteins are acylated, while few are prenylated. J. Biol. Chem.
274:3910–3917.
19. Xavier, R., T. Brennan, Q. Li, C. McCormack, and B. Seed.
1998. Membrane compartmentation is required for efficient
T cell activation. Immunity. 8:723–732.
20. Doucey, M.A., D.F. Legler, N. Boucheron, J.-C. Cerottini,
C. Bron, and I.F. Luescher. 2001. CTL activation is induced
by cross linking of TCR/MHC peptide-CD8/lck adducts in
rafts. Eur. J. Immunol. 31:1561–1570.
21. Montixi, C., C. Langlet, A.M. Bernard, J. Thimonier, C.
Dubois, M.A. Wurbel, J.P. Chauvin, M. Pierres, and H.T.
He. 1998. Engagement of T cell receptor triggers its recruit-
ment to low-density detergent-insoluble membrane domains.
EMBO J. 17:5334–5348.
22. Zhang, W., R.P. Trible, and L.E. Samelson. 1998. LAT
palmitoylation: its essential role in membrane microdomain
targeting and tyrosine phosphorylation during T cell activa-
tion. Immunity. 9:239–246.
23. Bosselut, R., W. Zhang, J.M. Ashe, J.L. Kopacz, L.E. Samel-
son, and A. Singer. 1999. Association of the adaptor mole-
cule LAT with CD4 and CD8 coreceptors identifies a new
coreceptor function in T cell receptor signal transduction. J.
Exp. Med. 190:1517–1526.
24. Deftos, M.L., Y.W. He, E.W. Ojala, and M.J. Bevan. 1998.
Correlating notch signaling with thymocyte maturation. Im-
munity. 9:777–786.
25. Hudrisier, D., B. Kessler, S. Valitutti, C. Horvath, J.-C.
Cerottini, and I.F. Luescher. 1998. The efficiency of antigen
recognition by CD8 CTL clones is determined by the fre-
quency of serial TCR engagement. J. Immunol. 161:553–562.
26. Willcox, B.E., G.F. Gao, J.R. Wyer, J.E. Ladbury, J.I. Bell,
B.K. Jakobsen, and P.A. van der Merwe. 1999. TCR bind-
ing to peptide-MHC stabilizes a flexible recognition inter-
face. Immunity. 10:357–365.
27. Thome, M., V. Germain, J.P. DiSanto, and O. Acuto. 1996.
The p56lck SH2 domain mediates recruitment of CD8/p56lck
to the activated T cell receptor/CD3 complex. Eur. J. Im-
munol. 26:2093–2100.
28. Suzuki, S., J. Kupsch, K. Eichmann, and M. Saizawa. 1992.
Biochemical evidence of the physical association of the ma-
jority of CD3 chains with the accessory/co-recptor mole-
cules CD4 and CD8 on nonactivated T lymphocytes. Eur. J.
Immunol. 22:2475–2479.
29. Beyers, A.D., L.L. Spruty, and A.F. Williams. 1992. Molecu-
lar association between the T-lymphocyte antigen receptor
complex and the surface antigens CD2, CD4, or CD8 and
1495 Arcaro et al.
CD5. Proc. Natl. Acad. Sci. USA. 89:2945–2949.
30. Gallagher, P.F., B. Fazekas de St. Groth, and J.A.A.P. Miller.
1989. CD4 and CD8 molecules can physically associate with
the same T cell receptor. Proc. Natl. Acad. Sci. USA. 86:
10044-10048.
31. Fremont, D.H., W.A. Rees, and H. Kozono. 1996. Biophys-
ical studies of T-cell receptors and their ligands. Curr. Opin.
Immunol. 8:93–100.
32. Delgado, P., E. Fernandez, V. Dave, D. Kappas, and B. Alar-
con. 2000. CD3 couples T-cell receptor signaling to ERK
activation and thymocyte positive selection. Nature. 406:426–
430.
33. Guy, W., B. Hausmann, and E. Palmer. 2000. A motif in the
T-cell receptor controls positive selection by modulating
ERK activity. Nature. 406:422–426.
34. Qian, D., and A. Weiss A. 1997. T cell antigen receptor sig-
nal transduction. Curr. Opin. Cell Biol. 9:205-212.
35. Webb, Y., L. Hermida-Matsumoto, and M.D. Resh. 2000.
Inhibition of protein palmitoylation, raft localization, and T
cell signaling by 2-bromopalmitate and poyunsaturated fatty
acids. J. Biol. Chem. 275:261–270.
36. Yasuda, K., A. Kosugi, F. Hayashi, S. Saitoh, M. Nagafuku,
Y. Mori, M. Ogata, and T. Hamaoka. 2000. Serine 6 of Lck
tyrosine kinase: a critical site for Lck myristoylation, mem-
brane localization, and function in T lymphocytes. J. Immu-
nol. 165:3226–3231.
37. Lin, J., A. Weiss, and T.S. Finco. 1999. Localization of LAT
in glycolipid-enriched microdomains is required for T cell
activation. J. Biol. Chem. 274:28861–28864.
38. Zhang, W., and L.E. Samelson. 2000. The role of mem-
brane-associated adaptors in T cell receptor signalling. Semin.
Immunol. 12:35–41.
39. Zhang, W., J. Sloan-Lancaster, J. Kitchen, R.P. Trible, and
L.E. Samelson. 1998. LAT: the ZAP-70 tyrosine kinase sub-
strate that links T cell receptor to cellular activation. Cell. 92:
83–92.
40. Janes, P.W., S.C. Ley, and A.I. Magee. 1999. Aggregation of
lipid rafts accompanies signaling via the T cell antigen recep-
tor. J. Cell Biol. 147:447–461.
41. van’t Hof, W., and M.D. Resh. 1999. Dual fatty acylation of
p59(Fyn) is required for association with the T cell receptor
zeta chain through phosphotyrosine-Src homology domain-2
interactions. J. Cell Biol. 145:377–389.
42. Yamaguchi, H., and W.A. Hendrickson. 1996. Structural ba-
sis for activation of human lymphocyte kinase Lck upon tyro-
sine phosphorylation. Nature. 384:484–489.
